enhanc
surveil
involv
collect
minimum
dataset
possibl
case
includ
demograph
data
clinic
symptom
travel
contact
histori
result
test
respiratori
pathogen
nose
throat
swab
specimen
possibl
lower
respiratori
tract
specimen
test
region
laboratori
although
test
guidelin
recommend
merscov
test
exclus
altern
etiolog
test
conduct
parallel
merscov
test
suspect
case
first
day
surveil
pancoronaviru
assay
conduct
phe
nation
refer
laboratori
use
screen
test
viral
genom
fulli
sequenc
gener
merscov
specif
assay
firstlin
screen
assay
target
viral
genom
area
upstream
e
gene
conduct
follow
confirmatori
test
hpaph
nation
refer
laboratori
result
merscov
test
report
regularli
hpaph
weekli
influenza
report
descript
analysi
includ
number
person
test
proport
posit
merscov
key
demograph
epidemiolog
clinic
characterist
posit
predict
valu
differ
combin
sign
symptom
calcul
proport
person
sign
symptom
mer
test
posit
merscov
show
exact
clopperpearson
binomi
confid
interv
septemb
travel
middl
east
met
possibl
case
definit
test
merscov
seventyf
travel
test
neg
screen
assay
test
posit
posit
result
screen
assay
confirm
posit
result
hpaph
nation
refer
laboratori
addit
test
person
met
possibl
case
criteria
merscov
test
conduct
patient
sever
acut
respiratori
diseas
meet
travel
requir
travel
histori
outsid
middl
east
travel
histori
relev
exposur
period
travel
histori
remain
unknown
merscov
detect
person
clinic
epidemiolog
characterist
person
test
merscov
test
result
shown
tabl
test
rang
age
month
year
sign
pulmonari
parenchym
involv
confirm
case
male
patient
year
age
sever
acut
respiratori
symptom
requir
treatment
extracorpor
membran
oxygen
subsequ
die
merscov
pcr
test
conduct
contact
confirm
casepati
england
contact
test
merscov
posit
posit
predict
valu
merscov
infect
differ
combin
sign
symptom
shown
tabl
casepati
pulmonari
parenchym
involv
test
posit
merscov
posit
predict
valu
clinic
manifest
increas
sever
diseas
increas
patient
test
posit
result
altern
respiratori
pathogen
includ
influenza
influenza
influenza
b
influenza
casepati
later
confirm
also
infect
merscov
two
casepati
test
posit
legionella
pneumophila
rhinoviru
adenoviru
respiratori
syncyti
viru
human
metapneumoviru
unlik
surveil
establish
organ
surveil
novel
pathogen
requir
analysi
inform
collect
patient
test
even
test
neg
build
knowledg
predict
valu
differ
epidemiolog
clinic
manifest
report
characterist
patient
travel
england
middl
east
test
merscov
enabl
first
crude
estim
posit
predict
valu
differ
sign
symptom
first
year
follow
emerg
pathogen
studi
base
cohort
suspect
casepati
laboratoryconfirm
case
identifi
surveil
period
estim
basi
identifi
symptom
imprecis
tabl
howev
context
emerg
pathogen
report
data
progress
help
optim
case
detect
surveil
system
surveil
period
patient
respiratori
symptom
pulmonari
parenchym
involv
posit
merscov
pcr
posit
predict
valu
sign
symptom
increas
sever
clinic
manifest
suggest
case
definit
use
period
recommend
merscov
test
patient
met
epidemiolog
criteria
sever
respiratori
ill
appropri
rang
respiratori
pathogen
found
patient
merscov
neg
highlight
import
look
altern
diagnos
howev
diagnosi
merscov
casepati
delay
initi
diagnosi
influenza
test
algorithm
subsequ
chang
ensur
patient
meet
possibl
case
definit
test
merscov
altern
etiolog
fulli
explain
clinic
manifest
predict
valu
possibl
case
definit
depend
incid
infect
would
expect
vari
across
differ
popul
group
chang
time
especi
context
emerg
pathogen
encourag
countri
similarli
report
characterist
patient
test
merscov
improv
understand
predict
valu
differ
clinic
epidemiolog
manifest
variou
popul
differ
time
help
inform
evolv
intern
public
health
respons
novel
pathogen
